A multidisciplinary approach is recommended for formulating the optimal treatment plan.[2] Owing to advancements in ultrasensitive GH assays, some experts propose adjusting the GH threshold for diagnosing acromegaly via the OGTT to 0.4 ng/mL, contingent on the assay utilized.[7] In this instance, the patient did not undergo an ultrasensitive GH test. This evidence concerns the gene GH1 and acromegaly.